Business

Innate Pharma to Participate in the Leerink Partners Global Healthcare Conference

MARSEILLE, France, February 18, 2026--Innate pharma to participate in the Leerink Partners Global Healthcare Conference

articleInnate Pharma Sa Class AFebruary 18, 20263/company/innate-pharma-sa-class-a/news/innate-pharma-to-participate-in-the-leerink-partners-global-healthcare-conference-1
Innate Pharma to Participate in the Leerink Partners Global Healthcare Conference

About this update from Innate Pharma Sa Class A

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/acad1010c66863319d012c73321e54f2"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/1aIOb06WKg6eItFdQBdEAg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/acad1010c66863319d012c73321e54f2","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/ctDW9OZzqZBfAsD1SLi2oQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/acad1010c66863319d012c73321e54f2","width":1024,"height":512}},"lazy":false},{"type":"text","content":"MARSEILLE, France, February 18, 2026--(BUSINESS WIRE)--Regulatory News:","length":71,"tagName":"p"},{"type":"text","content":"Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company"), a clinical-stage biotechnology company developing immunotherapies for cancer patients, today announced that members of its executive team will participate in a fireside chat and one-on-one meetings at the following conference:","length":328,"tagName":"p"},{"type":"text","content":"Leerink Partners Global Healthcare Conference 2026","length":50,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Dates: March 8–11, 2026","length":23,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Location: Miami, Florida, United States","length":39,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":62,"olType":false},{"type":"text","content":"Fireside chat:","length":14,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Date: March 9, 2026","length":19,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Time: 3:40 PM ET / 8:40 PM CET","length":30,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"To enter the live webcast, please click here","length":44,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":93,"olType":false},{"type":"text","content":"The link to access the live webcast of the presentation will be available on the Events page of the Investors section of Innate Pharma’s website. A replay of the presentation will be available following the event.","lengt...

More updates from Innate Pharma Sa Class A

Euronext ParisInnate PharmaIPHantibody therapeuticsfireside chatNasdaqbiotechnology company